Moderna-Merck skin cancer drug combo could reportedly launch in Europe in 2028
MRNA•A combination of Moderna’s mRNA cancer vaccine and Merck & Co’s immunotherapy could launch in the United States in 2027 and Germany and Europe in 2028, Moderna CEO Stephane Bancel said.
1. Possible launch timeline
The melanoma treatment combination could launch in Germany and Europe in 2028, Moderna CEO Stephane Bancel said. He said the United States launch would come first, in 2027.
